December 2002
Volume 43, Issue 13
Free
ARVO Annual Meeting Abstract  |   December 2002
Reproducibility of Retinal Thicknes Summary Parameters in Eyes with Diabetic Macular Edema
Author Affiliations & Notes
  • Y Ding
    Ophthalmology Wilmer Institute Johns Hopkins School of Medicine Baltimore MD
  • A Loewenstein
    Department of Ophthalmology Tel Aviv Medical Center Tel Aviv Israel
  • B Azmon
    Department of Ophthalmology Tel Aviv Medical Center Tel Aviv Israel
  • P Pianka
    Department of Ophthalmology Tel Aviv Medical Center Tel Aviv Israel
  • R Zeimer
    Ophthalmology Wilmer Institute Johns Hopkins School of Medicine Baltimore MD
  • S Vitale
    Ophthalmology Wilmer Institute Johns Hopkins School of Medicine Baltimore MD
  • Footnotes
    Commercial Relationships   Y. Ding, None; A. Loewenstein, None; B. Azmon, None; P. Pianka, None; R. Zeimer, Talia Technologies, Ltd. F, C, P, R; S. Vitale, Talia Technologies, Ltd. F. Grant Identification: NEI R03 EY12693(SV)
Investigative Ophthalmology & Visual Science December 2002, Vol.43, 539. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Y Ding, A Loewenstein, B Azmon, P Pianka, R Zeimer, S Vitale; Reproducibility of Retinal Thicknes Summary Parameters in Eyes with Diabetic Macular Edema . Invest. Ophthalmol. Vis. Sci. 2002;43(13):539.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Abstract: : Purpose: The goal of this study was to determine, in diabetic eyes, the reproducibility (standard error of measurement (Se)) of retinal thickness measurements assessed by the Retinal Thickness Analyzer (RTA, Talia Technologies, Ltd, Neve Ilan, Israel). The reproducibility is important in determining when a patient can be said to have a significant change in retinal thickness. Reproducibility of the RTA has been studied in normal and in glaucomatous eyes, but not in eyes with diabetic macular edema. We assessed the intra- and inter-operator reproducibilities (IaOR, IeOR) of foveal and parafoveal retinal thickness (RT) summary parameters in 26 eyes of 20 diabetic patients. Methods: The RTA is a scanning laser technology to obtain digital optical cross-sections over the macular region. An automated algorithm computes a RT map and summary parameters within regions of interest. RTA scans were obtained two times in the same day by two independent operators (total of 4 scans per eye) and independently aligned by an independent operator. RT summary parameters studied were mean foveal RT (FAV: 600-mm-radius circle), mean foveolar RT (VAV: 300-mm-radius circle), and mean parafoveal RT (PFAV: 6x6mm2 area excluding FAV). Results: In eyes with mild-to-moderate edema (RT values £ 300 mm (1.5x normal)), IaOR was about 1.5 times that of normal eyes (Se for FAV, VAV, PFAV:13.4, 15.9, 7.3 mm) for both operators. For mild-to-severe edema (RT values £ 500 mm (2.5x normal)), IaOR for operator 2 was similar: Se for FAV, VAV, and PFAV: 13.9, 12.8, and 5.9 mm. Operator 1's IaOR was dramatically worse for mild-to-severe edema (Se for FAV, VAV, and PFAV: 48.0, 34.0, 15.2 mm). IeOR was similar for mild-to-severe edema (Se for FAV, VAV, and PFAV: 13.5, 16.2, 10.3 mm). For eyes with very severe edema (RT values ≷ 500 mm (≷ 2.5x normal, usually associated with extensive cysts), IeOR was poor (Se for FAV, VAV, and PFAV: 191, 197, 147 mm). Conclusions: Change of 27 (9%), 33 (11 %), and 21 (7%) mm or more, in FAV, VAV, and PFAV, respectively, would constitute significant change for eyes with for mild-to-severe edema at baseline. In the early stages of macular edema, relatively small changes can be detected. These findings will allow more accurate characterization of significant changes in studies of new treatments for macular edema.

Keywords:  
×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×